140 related articles for article (PubMed ID: 25342374)
1. Tacrolimus in idiopathic inflammatory myopathy-associated interstitial lung disease: defining roles and responders.
Gordon P; Gooptu B
Rheumatology (Oxford); 2015 Jan; 54(1):3-4. PubMed ID: 25342374
[No Abstract] [Full Text] [Related]
2. Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
Nagashima T; Minota S
Rheumatology (Oxford); 2015 Jun; 54(6):1128-9. PubMed ID: 25832615
[No Abstract] [Full Text] [Related]
3. Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis: reply.
Yasuda S; Kurita T; Horita T; Atsumi T
Rheumatology (Oxford); 2015 Jun; 54(6):1129. PubMed ID: 25832614
[No Abstract] [Full Text] [Related]
4. Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis.
Ochi S; Nanki T; Takada K; Suzuki F; Komano Y; Kubota T; Miyasaka N
Clin Exp Rheumatol; 2005; 23(5):707-10. PubMed ID: 16173253
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
Kurita T; Yasuda S; Oba K; Odani T; Kono M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Atsumi T
Rheumatology (Oxford); 2015 Jan; 54(1):39-44. PubMed ID: 24764266
[TBL] [Abstract][Full Text] [Related]
6. [Coping with pathological changes in heart and lung in collagen diseases--dermatomyositis and interstitial pneumonia].
Nawata Y
Nihon Naika Gakkai Zasshi; 1996 Nov; 85(11):1850-4. PubMed ID: 9019505
[No Abstract] [Full Text] [Related]
7. Tacrolimus in refractory polymyositis with interstitial lung disease.
Oddis CV; Sciurba FC; Elmagd KA; Starzl TE
Lancet; 1999 May; 353(9166):1762-3. PubMed ID: 10347992
[No Abstract] [Full Text] [Related]
8. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review.
Ge Y; Zhou H; Shi J; Ye B; Peng Q; Lu X; Wang G
Clin Rheumatol; 2015 Dec; 34(12):2097-103. PubMed ID: 26328518
[TBL] [Abstract][Full Text] [Related]
9. Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide.
Meyer O; Hayem G; Palazzo E; Crestani B; Debray MP; Ballard M
Clin Exp Rheumatol; 2005; 23(5):724. PubMed ID: 16173257
[No Abstract] [Full Text] [Related]
10. [Pulmonary damage during polymyositis and dermatomyositis: interstitial lung disease].
Marie I; Dominique S
Presse Med; 2006 Apr; 35(4 Pt 2):683-95. PubMed ID: 16614615
[TBL] [Abstract][Full Text] [Related]
11. [Interstitial lung diseases in polymyositis and dermatomyositis].
Marie I; Dominique S; Rémy-Jardin M; Hatron PY; Hachulla E
Rev Med Interne; 2001 Nov; 22(11):1083-96. PubMed ID: 11817120
[TBL] [Abstract][Full Text] [Related]
12. Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.
Watanabe R; Ishii T; Araki K; Ishizuka M; Kamogawa Y; Fujita Y; Shirota Y; Fujii H; Harigae H
Mod Rheumatol; 2016; 26(3):465-6. PubMed ID: 25698368
[No Abstract] [Full Text] [Related]
13. Fatal acute interstitial pneumonitis complicating polymyositis in a 41-year-old man.
Aoun NY; Velez E; Aggarwal A; Hayes GB; Kenney LA
Respir Care; 2004 Dec; 49(12):1515-21. PubMed ID: 15571643
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary lesions in collagen diseases--special reference to interstitial pneumonia with polymyositis-dermatomyositis].
Fukuda T
Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1865-70. PubMed ID: 10581775
[No Abstract] [Full Text] [Related]
15. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
Maeda K; Kimura R; Komuta K; Igarashi T
Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798
[TBL] [Abstract][Full Text] [Related]
16. Biologics in polymyositis and dermatomyositis-associated interstitial lung disease.
Sun Y; He Y; Liu Y; Shi G
Curr Pharm Biotechnol; 2014; 15(6):521-4. PubMed ID: 25213360
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
Kurita T; Yasuda S; Amengual O; Atsumi T
Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease in polymyositis and dermatomyositis.
Schnabel A; Hellmich B; Gross WL
Curr Rheumatol Rep; 2005 Apr; 7(2):99-105. PubMed ID: 15760588
[TBL] [Abstract][Full Text] [Related]
19. Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.
Moghadam-Kia S; Aggarwal R; Oddis CV
Expert Rev Clin Immunol; 2015; 11(11):1265-75. PubMed ID: 26313852
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine.
Ando M; Miyazaki E; Yamasue M; Sadamura Y; Ishii T; Takenaka R; Ito T; Nureki S; Kumamoto T
Clin Rheumatol; 2010 Apr; 29(4):443-5. PubMed ID: 20130943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
